Medicenna Therapeutics Corp. (TSX:MDNA)

CTI BioPharma Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	20.46	24.84	16.98	33.6	20.54	30.38
Trading Asset Securities	-	-	-	-	-	10.01
Cash & Short-Term Investments	20.46	24.84	16.98	33.6	20.54	40.39
Cash Growth	-42.58%	46.26%	-49.45%	63.60%	-49.15%	7.12%
Other Receivables	1.17	2.7	1.16	0.86	1.31	0.41
Receivables	1.17	2.7	1.16	0.86	1.31	0.41
Prepaid Expenses	0.95	0.64	0.93	1.93	1.55	1.35
Total Current Assets	22.58	28.17	19.08	36.39	23.39	42.15
Property, Plant & Equipment	0.14	0.16	-	-	-	0.03
Other Intangible Assets	0.05	0.05	0.06	0.06	0.07	0.07
Total Assets	22.77	28.38	19.13	36.45	23.46	42.25
Accounts Payable	4.51	2.7	2.07	1.62	1.67	2.25
Accrued Expenses	-	1.69	0.79	2.18	0.95	1.83
Current Portion of Leases	0.06	0.05	-	-	-	0.03
Other Current Liabilities	-	-	-	3.16	-	-
Total Current Liabilities	4.57	4.44	2.86	6.96	2.62	4.11
Long-Term Leases	0.1	0.12	-	-	-	-
Other Long-Term Liabilities	3.45	4.73	11.08	-	-	-
Total Liabilities	8.13	9.29	13.94	6.96	2.62	4.11
Common Stock	126.23	116.3	100.92	100.92	83.67	79.59
Additional Paid-In Capital	11.56	11.22	10.7	9.49	7.93	6.68
Retained Earnings	-123.18	-118.25	-106.45	-80.98	-70.93	-48.36
Comprehensive Income & Other	0.04	9.83	0.02	0.06	0.17	0.23
Total Common Equity	14.64	19.1	5.19	29.49	20.84	38.15
Shareholders' Equity	14.64	19.1	5.19	29.49	20.84	38.15
Total Liabilities & Equity	22.77	28.38	19.13	36.45	23.46	42.25
Total Debt	0.16	0.17	-	-	-	0.03
Net Cash (Debt)	20.3	24.67	16.98	33.6	20.54	40.35
Net Cash Growth	-43.03%	45.27%	-49.45%	63.60%	-49.11%	7.22%
Net Cash Per Share	0.26	0.32	0.24	0.52	0.38	0.81
Filing Date Shares Outstanding	82.52	83.38	76.18	69.64	56.3	53.55
Total Common Shares Outstanding	82.52	78.22	69.64	69.64	55.65	53.55
Working Capital	18.01	23.74	16.21	29.43	20.77	38.04
Book Value Per Share	0.18	0.24	0.07	0.42	0.37	0.71
Tangible Book Value	14.59	19.04	5.13	29.43	20.77	38.07
Tangible Book Value Per Share	0.18	0.24	0.07	0.42	0.37	0.71

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.